Mid-Year Report

APOTEX CORP. for APOTEX CORP.

Firm
Client
Income
—
Expenses
$118,300

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Centers for Medicare and Medicaid Services Rule 2238-P concerning Medicaid prescription drug reimbursement

LobbyistCovered position, as disclosed
STEVEN GIULI N/A

Contacted: Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

HR 1908, Patent Reform Act of 2007 S. 1145, Patent Reform Act of 2007

LobbyistCovered position, as disclosed
STEVEN GIULI N/A

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Food & Drug Administration (FDA)

Bills named: S. 1145 (110th), H.R. 1908 (110th)

Budget/Appropriations BUD

HR 3161, FY 2008 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations -- Office of Generic Drug Funding S 1859, FY 2008 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations -- Office of Generic Drug Funding

LobbyistCovered position, as disclosed
STEVEN GIULI N/A

Contacted: Federal Trade Commission (FTC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3161 (110th)

Pharmacy PHA

S 1695, Biologics Price Competition and Innovation Act S. 1088, Lower Priced Drugs Act S. 1082, the Food and Drug Administration Revitalization Act, including Title VIII, Importation of Prescription Drugs (Section 6, Wholsale Distribution of Drugs) S AMDT 1011 on Citizen Petitions HR 2900 Food and Drug Administration Amendments of 2007, including provisions concerning the citizen petition process Reauthorization of Pediatric Exclusivity program in House and Senate Abbreviated New Drug Application No. 76-396 for calcitonin-salmon nasal spray S. 316, the Preserve Access to Affordable Pharamceuticals Act HR 1902, Protecting Consumer Access to Generic Drugs Act HR 1038, Access to Life Savings Medicine Act S 623, Access to Life Savings Medicine Act

LobbyistCovered position, as disclosed
STEVEN GIULI N/A

Contacted: Food & Drug Administration (FDA); Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2900 (110th), S. 1082 (110th), H.R. 1902 (110th), S. 316 (110th), S. 1088 (110th), H.R. 1038 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.